Rationale and design of a multicenter, international and collaborative Coronary Artery Aneurysm Registry (CAAR)

Iván J Núñez-Gil1, Luis Nombela-Franco1, Rodrigo Bagur2

  • 1Cardiovascular Institute, Hospital Clínico San Carlos and Department of Medicine, Complutense University, Madrid, Spain.

Clinical Cardiology
|March 25, 2017
PubMed

Insights

Coronary artery aneurysms are uncommon dilations of heart arteries. The Coronary Artery Aneurysm Registry (CAAR) aims to clarify their causes, outcomes, and optimal treatments.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Medical Research

Background:

  • Coronary artery aneurysm (CAA) is defined as a coronary dilation exceeding adjacent segments by 1.5×.
  • CAA is uncommon, with reported incidence of 1.5–5%, predominantly in males and affecting the right coronary artery.
  • Atherosclerosis is the primary cause in adults (>50%), with complications including thrombosis, rupture, and vasospasm.

Purpose of the Study:

  • To investigate the anatomic, epidemiologic, and clinical characteristics of coronary artery aneurysms.
  • To evaluate management strategies, including conservative, interventional, and surgical approaches.
  • To assess the short- and long-term outcomes of patients with coronary artery aneurysms.

Main Methods:

  • The Coronary Artery Aneurysm Registry (CAAR) is a multicenter, international, ambispective registry.
  • Utilizes data from a large cohort of patients diagnosed with coronary artery aneurysms.
  • Collects data on patient demographics, aneurysm characteristics, and treatment strategies.

Main Results:

  • Data on the natural history and prognosis of CAA are scarce.
  • Controversies exist regarding optimal medical versus interventional/surgical management.
  • The registry aims to provide definitive data on this understudied condition.

Conclusions:

  • Coronary artery aneurysms are poorly understood, with limited data on natural history and prognosis.
  • The CAAR registry is crucial for elucidating CAA's epidemiology, clinical aspects, and optimal management.
  • Further research is needed to establish evidence-based guidelines for CAA treatment.

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
414
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
449
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
351
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
352
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
662
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K